Chapter
Advances in Cancer Treatment: The Promise of CAR T Cells
1:15:47 - 1:22:22 (06:35)
This podcast discusses the promise of CAR T-cell therapy in cancer treatment, allowing for the targeted destruction of specific cancer cells in a patient's body. The conversation also touches on the potential risks of holding the line on sanctions and running massive deficits for emerging market countries.
Clips
The decision to maintain sanctions could lead to increased risk for emerging markets countries rather than developed countries such as America, Europe, Canada, and Japan.
1:15:47 - 1:19:18 (03:31)
Summary
The decision to maintain sanctions could lead to increased risk for emerging markets countries rather than developed countries such as America, Europe, Canada, and Japan. While it may be a reasonable way to manage risk in developed countries, emerging market countries could be faced with increased gas prices and risks associated with running massive deficits.
ChapterAdvances in Cancer Treatment: The Promise of CAR T Cells
EpisodeE71: Russia/Ukraine deep dive: escalation, risk factors, financial fallout, exit ramps and more
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
In this episode, the speaker explains how CRISPR is used to engineer T cells for targeted cancer therapy, which can be more effective than traditional chemotherapies and lead to complete remission of cancer cells in the body.
1:19:18 - 1:22:22 (03:04)
Summary
In this episode, the speaker explains how CRISPR is used to engineer T cells for targeted cancer therapy, which can be more effective than traditional chemotherapies and lead to complete remission of cancer cells in the body.